Thursday, September 26, 2013

Minimise transmission risk of CJD and vCJD in healthcare settings

Guidance

Minimise transmission risk of CJD and vCJD in healthcare settings


Guidance on prevention of CJD and vCJD by Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup.

Documents

Introduction

Annex A2: Distribution of infectivity in animal tissue and body fluids

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accesible format please email publications@dh.gsi.gov.uk quoting your address, telephone number along with the title of the publication ("Annex A2: Distribution of infectivity in animal tissue and body fluids").

Annex B: Diagnostic criteria

Annex F: Endoscopy

Annex H: After death

CJD guidance for ophthalmologists

Frequently asked questions

Abbreviations

Acknowledgements




Detail

This guidance produced by the Advisory Committee on Dangerous Pathogens’ Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup aims to help minimise the risk of transmission of CJD and vCJD in healthcare and other work settings.


Links to this post:

Create a Link

<< Home